Southwest Securities: Innovative Drug Special Topic —— China's Voice Resounds at the 2026 JPM Conference

J.P. Morgan Healthcare Conference, which began in 1982, is one of the most influential and largest healthcare investment industry exchange and cooperation conferences in the global healthcare field. It covers the entire healthcare spectrum, including pharmaceuticals, biotechnology, medical devices, diagnostics, digital health, and medical services, making it a top-tier business feast of "capital + strategy."

The JPM Conference is the largest and most information-rich investment and partnership event in the healthcare field, bringing together the world's most influential multinational pharmaceutical companies (MNCs), innovative drug companies (Biotech), and investment institutions. It not only provides a platform for MNCs, investment institutions, and Biotech to connect but also sends out clear signals for the industry’s development in the coming year, offering important guidance for the direction of the global biopharmaceutical industry. By reviewing the JPM Conference, it is not difficult to find that innovative drug companies, especially those with expected BD transactions, often experience significant stock price catalysts. Therefore, the annual JPM Conference is a key event for investment in the innovative drug industry.